The Measurement Of Cerebral Oxygenisation With NIRS Method İn Polycythaemic Infants Might Add A Criterion To Indicate PPET?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01255618|
Recruitment Status : Unknown
Verified November 2010 by Zekai Tahir Burak Women's Health Research and Education Hospital.
Recruitment status was: Recruiting
First Posted : December 7, 2010
Last Update Posted : December 7, 2010
|Condition or disease||Intervention/treatment|
|Cerebral Oxygenation Peripheric Oxygenation Polycythaemic Infants||Device: INVOS 5100|
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Study Start Date :||November 2010|
|Estimated Primary Completion Date :||December 2010|
|Estimated Study Completion Date :||January 2011|
|study group, control group||
Device: INVOS 5100
Near-infrared range and has been used in newborn infants since 1985. Fibre-optic bundles or optodes are placed either on opposite sides of the tissue being interrogated (usually a limb or the head of a young baby) to measure transmitted light, or close together to measure reflected light. Light enters through one optode and a fraction of the photons is captured by a second optode and conveyed to the measuring device. NIRS uses a frequency band between 650 nm and 1000 nm and relies on three important phenomena: (1) human tissue is relatively transparent to light in the near-infrared region of the spectrum; (2) pigmented compounds known as chromophores absorb light as it passes through biological tissue; and (3) human tissues contain substances whose absorption spectra at near-infrared wavelengths are well defined and depend on their oxygenation status.
- cerebral oxygenation measurement [ Time Frame: 6 months ]
Biospecimen Retention: None Retained
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01255618
|Contact: ugur dilmen, proff||+90 312 506 email@example.com|
|Zekai Tahir Maternity Teaching Hospital||Recruiting|
|Ankara, Altındag, Turkey, 06330|
|Contact: gonca sandal, M.D. +90 505 487 10 27 firstname.lastname@example.org|